Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Special Report on African Mango By PowerSupplements.Com Looks to Uncover Facts

 

Perfect African Mango




African Mango and Dr Oz


(EMAILWIRE.COM, April 12, 2012 ) New York, NY -- There is one indisputable fact about African Mango – it is controversial! On one side, people claiming that African Mango (or Irvingia Gabonensis) is the most powerful weight loss supplement to come around in years. On the other side are the people who see African Mango as just the latest “miracle pill” that will only help lose weight in the wallet.



To help separate fact from fiction when it comes to the African Mango, PowerSupplements.Com has just completed on special report on African Mango supplements and research. The purpose of the report is to provide objective, unbiased information on African Mango and African Mango supplements, so consumers can make well informed decisions.



In the African Mango Special Report PowerSupplements addresses topics such as:



· Does African Mango Really Help With Weight Loss?

· What Did Dr. Oz Really Say About African Mango?

· Has An African Mango Dosage Been Established?

· Are All African Mango Supplements The Same?

· What is IGOB131 And Why Is It Important?

· Have There Been Clinical Studies done On African Mango?



“The point of the report is to establish what we know and don’t know about African Mango and African Mango Supplements as it pertains to weight loss. There is so much wrong and misleading information online, we wanted to provide a good starting point for people looking to learn more about African Mango” states Bob Peters, Director of Communications for PowerSupplements.Com .



African Mango exploded on the scene when Dr. Oz mentioned it on his show in May 2011. The Doctor Oz show focused on products that could help woman over the age of 40. In the segment, Dr Oz, talked about how African Mango could help women lose 10 pounds. Ever since that show aired, that has been tremendous interest in African Mango and African Mango supplements.



Even before Dr Oz picked up on African Mango, there was a great deal of buzz due to a a study published in the Journal of Lipids and Disease. In the study, a group of overweight adults who took IGOB131 (an African Mango seed extract), twice a day (150mg per serving), lost significantly more weight than the group taking a placebo. At the end of 10 weeks, the IGOB131™ group lost an average of 28 pounds, 6.7 inches from their waistline and reduced body fat by 18.4%.

Peters concludes, “African Mango is a very interesting ingredient and the initial clinical studies have been strong. People do need to learn the difference between IGOB131 and other African Mango supplements. We hope our special report will provide the necessary information to get people going on African Mango.”



About PowerSupplements:



PowerSupplements.Com is the site where science and supplements meet. PowerSupplements provides research and information on the most popular nutritional supplements so that consumers can make informed decisions. PowerSupplements.Com has been providing information and research since 1999.



For More Information Please Visit http://www.powersupplements.com

PowerSupplements
Bob Peters
(212) - 535 - 5083
questions@powersupplements.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Monsanto rejects Bayer bid, but open to more talks
25 May 2016 at 3:16am

Monsanto Co, the world's largest seed company, turned down Bayer AG's $62 billion acquisition bid as "incomplete and financially inadequate" on Tuesday, but said it was open to engage further in negotiations. Monsanto's decision, first reported earlier on Tuesday by Reuters, puts pressure on Bayer to decide whether to raise its bid, even as the company faces criticism from some shareholders that its $122-per-share cash offer is already too high. Monsanto shares ended trading up 3.1 percent at $109.3 in New York, substantially below Bayer's bid price, underscoring some investor skepticism that a deal can be done.


Israeli firms develop high-speed 3D printer for stem cells
25 May 2016 at 3:12am
Israeli 3D printer firm Nano Dimension has successfully lab-tested a 3D bioprinter for stem cells, paving the way for the potential printing of large tissues and organs, the company said on Wednesday. While 3D printers are used already to create stem cells for research, Nano Dimension said the trial, conducted with Israeli biotech firm Accellta Ltd, showed its adapted printer could make large volumes of high resolution cells quickly. "3D bioprinting enabled by the two companies' technologies, means that Nano Dimension and Accellta have the potential to accelerate high fidelity and high viability manufacturing of living cellular products," the companies said.


Novartis willing to sell Roche stake without demanding premium - CEO
25 May 2016 at 2:43am

Swiss drugmaker Novartis is ready to sell its near $14 billion stake in rival Roche without demanding a premium, Chief Executive Joe Jimenez said on Wednesday. Novartis has been discussing options with banks for selling its Roche shares worth about 13.70 billion Swiss francs ($13.81 billion), potentially providing cash for new deals, sources familiar with the situation told Reuters last month. It built up its one-third stake in Roche voting stock between 2001 and 2003 under former Chairman Daniel Vasella for a possible merger that never happened.



French drugmaker Sanofi to step up push into China
25 May 2016 at 2:05am

By Matthias Blamont and Noëlle Mennella PARIS (Reuters) - Sanofi will step up its push into China, its second biggest market after the United States, in the next five years as part of a wider expansion into emerging countries, where it sees a large part of its future growth. "In the past years we have always managed to come up with a 5-10 percent growth in emerging economies and I think we will remain in this range this year, even if we should be closer to 5 percent than 10 percent," Peter Guenter, Sanofi's executive vice president for general medicines and emerging markets, said in an interview with Reuters. Emerging markets, with expanding middle-class populations, are a big opportunity for global drug companies, although growth rates have slowed in recent years.


South Africa's Tsogo Sun posts 12 pct rise in full-year profit
25 May 2016 at 1:58am
Africa's biggest hotels and gambling operator, Tsogo Sun Holdings Ltd, said a recovery in its home market of South Africa in the last three months helped it achieve a 12 percent rise in full-year profit. The company, which also operates hotels in Nigeria, Kenya and Mozambique, said headline earnings per share (EPS) came in at 196.5 cents in the year to end-March, from 175 cents a year earlier. Both gambling and accommodation sales grew more than expected in the last quarter of the reporting period, Tsogo Sun Chief Executive Marcel von Aulock told Reuters on Wednesday.

AGs: Pelvic mesh implants caused dire complications
25 May 2016 at 1:39am
SEATTLE (AP) ? Dawna Hankins was scheduled to have a partial hysterectomy in 2008 when her doctor suggested implanting a vaginal mesh device at the same time to deal with minor incontinence.


Drug discovery brings hope of new breast cancer treatments
25 May 2016 at 1:36am

Scientists from the University of Edinburgh, Scotland, have identified a new drug that could offer an effective future therapy for breast cancer. While a potential treatment is still a long way off, this discovery could give rise to promising clinical trials. The potentially life-changing compound for women suffering from breast cancer is called eCF506.



Childhood goes up in smoke for Indonesian tobacco farm workers
25 May 2016 at 1:15am

By Prasto Wardoyo and Eveline Danubrata PROBOLINGGO, Indonesia (Reuters) - Thirteen-year-old Siti Maryam says she suffers headaches and nausea after harvesting tobacco leaves with her bare hands during four years of working on her family's farm in Indonesia. Maryam, who is among the thousands of children a rights group says work in hazardous conditions on farms in the world's fifth-biggest producer of tobacco, spoke to Reuters in a field near the east Java city of Probolinggo. "I feel dizzy, get headaches and feel like vomiting," said Maryam, listing symptoms that match a condition experts call acute nicotine poisoning, or "green tobacco sickness".



Uptick in colon cancer rates among people under 50
25 May 2016 at 12:21am

Colon cancer among people under 50 is on the rise, and tumors are often diagnosed at an advanced stage, according to research presented Tuesday. "While the healthcare system has done a great deal to address colorectal cancer in people over 50 -- heightening patient awareness and increasing screenings -- our findings show that much more needs to be done to fight this cancer in people under 50, a group not normally considered at risk," said lead author Elie Sutton, a research fellow at Mt. Sinai West Hospital in New York. "Not only did we find that the rate of colorectal cancer in this group is rising, we also saw that within the group that was diagnosed at a younger age, a higher percentage were diagnosed at later stages of cancer (stage three or four), which is very concerning," she added.


Machine learning radiology startup Zebra raises $12 million
24 May 2016 at 11:51pm
TEL AVIV (Reuters) - Israel's Zebra Medical Vision raised $12 million in a funding round led by Utah-based healthcare provider Intermountain Healthcare, with the participation of existing investors. Intermountain plans to work with Zebra to accelerate the creation of imaging algorithms to improve patient care. Zebra Medical, founded in 2014, seeks to teach computers to automatically read and diagnose medical imaging data. Its analytics engine helps physicians and healthcare providers analyze millions of imaging records. ...

FDA panel recommends approval of Novo Nordisk diabetes drug
24 May 2016 at 11:25pm
A U.S. advisory panel on Tuesday recommended approval of a new diabetes drug made by Novo Nordisk A/S that combines two of its existing treatments in a fixed-dose combination designed to be both effective and convenient. The panel voted 16-0 that the Food and Drug Administration should approve the drug, iDegLira, for patients with type 2 diabetes. The FDA is not obliged to follow the advice of its advisory panels but typically does so.

Drop in deaths in Mediterranean is hopeful sign, migration body says
24 May 2016 at 11:18pm
By Stephanie Nebehay GENEVA (Reuters) - Fewer migrants are dying as they try to cross the Mediterranean to Europe, which may reflect better management of refugee flows and swifter rescue operations, the International Organization for Migration (IOM) said on Tuesday. The death toll included 13 in May, none of them on the eastern Mediterranean route between Turkey and Greece, where arrivals have slowed to a trickle since the European Union struck an agreement with Turkey to get it to curb the flow.


Diagnosis app scoops Africa health prize
24 May 2016 at 9:48pm

An app that allows rural doctors to seek advice remotely from experts on Tuesday won Africa's first prize recognising new technology that boosts health on the continent. The award's main sponsor, French international public radio station RFI, said the 15,000-euro ($16,700) grant had been awarded in Dakar to Cheick Oumar Bagayoko, "a young Malian doctor and computer engineer".



Exclusive: Sanofi to unveil challenge to Medivation's board - sources
24 May 2016 at 9:37pm

France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter. Sanofi has threatened to oust the board after Medivation rejected its unsolicited $9.3 billion acquisition offer late last month, taking advantage of a so-called 'written consent' rule that gives Medivation shareholders the ability to act at any time to replace directors. Medivation has declined to engage in sale talks with Sanofi unless the latter raises its $52.50 per share cash offer first, sources have said.



Drugs and dung a bad mix for climate: study
24 May 2016 at 5:29pm

Scientists have discovered a potential threat to Earth's climate lurking in a dark and smelly place: the dung of cattle treated with antibiotics, a study said Wednesday. Lab studies revealed that dung pats from animals given a common antibiotic gave off more than double the methane, a potent greenhouse gas, than those of non-treated cows, a team wrote in the journal Proceedings of the Royal Society B. This highlights another danger of routinely using antibiotics on livestock, a practice which has already created a wave of drug resistance in humans.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC